Phosphodiesterase 4 short form (PDE4 (short form))

Phosphodiesterase 4 short form refers to a subgroup of splice variants/isoforms of the Phosphodiesterase 4 (PDE4) enzyme family. PDE4 short forms are characterized structurally by the presence of only the UCR2 (Upstream Conserved Region 2) domain and the catalytic domain, lacking UCR1, which distinguishes them from long and super-short forms. The absence of UCR1 results in fully active enzymes whose activity is primarily regulated transcriptionally, in contrast to the phosphorylation-dependent regulation seen in long forms. Functionally, PDE4 short forms hydrolyze cAMP, controlling the amplitude and duration of cAMP signaling, which is critical in immune, inflammatory, and neuronal processes. The short forms are predominantly cytosolic, play roles in various physiological and pathological processes, and are targets for diverse PDE4 inhibitors used or investigated therapeutically in inflammation, depression, COPD, and neurodegenerative diseases.

Other names

PDE4 short isoformPDE4 short variantPDE4D short formPDE4B2 (example of a short form, but specific gene context may apply)

Inhibition of PDE4 short form increases intracellular cAMP levels by preventing its hydrolysis, resulting in downstream effects such as anti-inflammatory and neuroprotective actions.